SCHEMBL2380170

SCHEMBL2380170

O=C(O)c1ccc(C2(C(F)(F)F)N=N2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.51
TSHR P16473 3/20 0.46
TP53 P04637 1/20 0.46
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44
SRD5A2 P31213 3/20 0.44
HPGD P15428 1/20 0.44
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA12 O43570 1/20 0.40
CA3 P07451 1/20 0.40
TYR P14679 1/20 0.40
DRD1 P21728 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
CA5A P35218 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20809262 0.83 KIF11 (0.50) KIF11ALDH1A1NOS1
SCHEMBL13073461 0.83 KIF11 (0.50) KIF11HPGDSMN1; SMN2NOS1PDK2
SCHEMBL26598413 0.81 KIF11 (0.49) KIF11NOS1PDK2
SCHEMBL19733924 0.80 KIF11 (0.48) KIF11CA2NOS1
SCHEMBL14655025 0.80 KIF11 (0.51) KIF11TSHRHPGDCA2SMN1; SMN2
SCHEMBL26598417 0.80 KIF11 (0.44) KIF11TSHRTP53ALDH1A1NOS1
SCHEMBL30192521 0.79 AKR1C3 (0.44) KIF11SRD5A2HPGDCA1CA2
SCHEMBL7797061 0.79 AKR1C3 (0.44) KIF11SRD5A2HPGDCA1CA2
SCHEMBL24534621 0.79 KIF11 (0.50) KIF11TSHRCA1CA2CA12
SCHEMBL17865303 0.79 KIF11 (0.47) KIF11HPGDALDH1A1SMN1; SMN2NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025262634-A1 ANGIOGRAPHIC IMAGE PROCESSING METHOD AND SYSTEM UNIVERSITA' DEGLI STUDI DI TORINO (IT) 2025-12-26 WO claimed
CN-118695639-A Full-fluorescence white light organic light-emitting layer and preparation method and application thereof 北京信息科技大学 2024-09-24 CN claimed
WO-2024140324-A1 BANDWIDTH ASSIGNMENT AND FEATURE DETERMINATION METHOD, OPTICAL LINE TERMINAL, COMPUTING SERVER, AND MEDIUM 中兴通讯股份有限公司 2024-07-04 WO claimed
CN-118282979-A Bandwidth allocation and feature determination method, optical line terminal, calculation server and medium 中兴通讯股份有限公司 2024-07-02 CN claimed
CN-114805740-B Solvent-free TDI trimer polyurethane acrylate and preparation method thereof 江西五行材料科技有限公司 2024-04-30 CN claimed
CN-116891480-A Preparation method and application of multiple stimulus response spiropyran photochromic material 浙江理工大学嵊州创新研究院有限公司 2023-10-17 CN claimed
CN-116355226-A Organic phosphorescent material and preparation method and application thereof 闽都创新实验室 2023-06-30 CN claimed
CN-114805740-A Solvent-free TDI tripolymer urethane acrylate and preparation method thereof 广州五行材料科技有限公司 2022-07-29 CN claimed
US-20260150509-A1 Display Apparatus LG DISPLAY CO., LTD. (KR) 2026-05-28 US disclosed
US-20260150569-A1 DISPLAY DEVICE LG DISPLAY CO., LTD. (KR) 2026-05-28 US disclosed
US-20260150505-A1 Display Device LG DISPLAY CO., LTD. (KR) 2026-05-28 US disclosed
US-20260150548-A1 DISPLAY APPARATUS LG DISPLAY CO., LTD. (KR) 2026-05-28 US disclosed
CN-122094331-A Display device 2026-05-26 CN disclosed
CN-122094330-A Display device 2026-05-26 CN disclosed
US-20080124809-A1 Method of Interaction Observation RIKEN (JP) 2008-05-29 US disclosed
US-20080124809-A1 Method of Interaction Observation RIKEN (JP) 2008-05-29 US disclosed
US-20070266775-A1 Method for producing a biosensor FUJIFILM CORPORATION (JP) 2007-11-22 US disclosed
US-20070266775-A1 Method for producing a biosensor FUJIFILM CORPORATION (JP) 2007-11-22 US disclosed
WO-2007026972-A2 BINDING PROTEIN MOLECULE CANON KABUSHIKI KAISHA (JP) 2007-03-08 WO disclosed
WO-2007020453-A2 PEPTIDE / PROTEIN IDENTIFICATION USING PHOTOREACTIVE CARRIERS FOR THE IMMOBILISATION OF THE LIGANDS UNIVERSITY OF WARWICK (GB) 2007-02-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260150505-A1 Display Device ICOSLG, CD2, L1CAM KIF11 2436/4885TSHR 1537/4885TP53 1963/4885
US-20260150569-A1 DISPLAY DEVICE OCIAD1, OCIAD2, CALD1 KIF11 2632/4885TSHR 2161/4885TP53 1344/4885
US-20260150509-A1 Display Apparatus OCIAD2, OCIAD1, CD2 KIF11 3187/4885TSHR 833/4885TP53 2347/4885
US-20260150548-A1 DISPLAY APPARATUS L1CAM, MAP1LC3B, PDCD4 KIF11 1786/4885TSHR 2064/4885TP53 2093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.